Tom Cornelis Pieter Wal

Mr. Tom Cornelis Pieter Wal

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SRStefan G. van Ravensteijn
Stefan G. van Ravensteijn
MNMaikel Johannes Leonardus Nederkoorn
Maikel Johannes Leonardus Nederkoorn
Tom Cornelis Pieter WalTom Cornelis Pieter Wal
Tom Cornelis Pieter Wal
YVYvonne MH Versleijen-Jonkers
Yvonne MH Versleijen-Jonkers
PBPètra M. Braam
Pètra M. Braam
JRJacky W. J. de Rooy
Jacky W. J. de Rooy
To improve local control, neoadjuvant radiotherapy (nRT) followed by surgery is the standard of care in myxofibrosarcoma (MFS) because of its infiltrative growth pattern. Nevertheless, local recurrence rates are high. Data on prognostic factors for poor clinical outcomes are lacking. This retrospective study thus investigates the prognostic relevance of magnetic resonance imaging (MRI) characteristics before and after nRT in 40 MFS patients, as well as their association with disease-free survival (DFS) and overall survival (OS). A vascular pedicle, defined as extra-tumoral vessels at the tumor periphery, was observed in 12 patients (30.0%) pre-nRT and remained present post-nRT in all cases. Patients with a vascular pedicle had worse DFS (HR 5.85; 95% CI 1.56–21.90; p = 0.009) and OS (HR 9.58; 95% CI 1.91–48.00; p = 0.006). An infiltrative growth pattern, referred to as a tail sign, was observed in 22 patients (55.0%) pre-nRT and in 19 patients (47.5%) post-nRT, and was associated with worse DFS post-nRT (HR 6.99; 95% CI 1.39–35.35; p = 0.019). The percentage of tumor necrosis estimated by MRI was increased post-nRT, but was not associated with survival outcomes. The presence of a tail sign or vascular pedicle on MRI could support the identification of patients at risk for poor clinical outcomes after nRT.

15 September 2026 in ESMO Rare Cancers
Verified
Journal Article
Open access
Tom Cornelis Pieter WalTom Cornelis Pieter Wal
Tom Cornelis Pieter Wal
JSJ.M. van Sabben
J.M. van Sabben
NSNeeltje Steeghs
Neeltje Steeghs
HGH. Gelderblom
H. Gelderblom
AOA.W. Oosten
A.W. Oosten
IDIngrid M.E. Desar
Ingrid M.E. Desar